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ABSTRACT 
Objective: The major objective of the research work was to design, characterise and evaluate controlled release microspheres of ropinirole 
hydrochloride by using non-aqueous solvent evaporation technique to facilitate the delivery of the drug at a predetermined rate for a specific period 
of time. 
Methods: Ropinirole hydrochloride microspheres were prepared by using different low-density polymers such as eudragit RL 100, eudragit RS 100 
and ethylcellulose either alone or in combination with the help of non-aqueous solvent evaporation technique. All the formulated microparticles 
were subjected to various evaluation parameters such as particle size analysis, micrometric properties, drug entrapment efficiency, percentage drug 
loading, percentage yield and in vitro drug release study. The compatibility of the drug and polymers was confirmed by physical compatibility study, 
fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and x-ray diffraction study (XRD). The formation of the 
most optimized batch of the microsphere (F12) was confirmed by scanning electron microscopy (SEM), DSC, FTIR, and XRD. In vitro drug release 
study and in vitro drug release kinetics study of the formulated microspheres were also carried out. 
Results: Drug-polymer compatibility studies performed with the help of FTIR and DSC indicated that there were no interactions. Results revealed 
that non-aqueous solvent evaporation technique was a suitable technique for the preparation of microspheres as most of the formulations were 
discrete, free-flowing and spherical in shape with a good yield of 55.67% to 80.09%, percentage drug loading of 35.52% to 94.50% and percentage 
drug entrapment efficiency of 36.24% to 95.07%. Different drug-polymer ratios, as well as the combination of polymers, played a significant role in 
the variation of over-all characteristics of formulations. Based on the data of various evaluation parameters such as particle size analysis, 
percentage drug loading, percentage drug entrapment, percentage yield, rheological studies and in vitro drug release characteristics, formulation 
F12 was found to fulfil the criteria of ideal controlled release drug delivery system. F12 showed controlled release till the 14th hour (97.99%) and 
its in vitro release kinetics was best explained by zero-order kinetics and followed Korsemeyer-Pappas model (Non-Fickian mechanism). SEM of 
F12 revealed the formation of spherical structures. The FTIR study of F12 confirmed the stable nature of ropinirole in the drug-loaded 
microspheres. DSC and XRD patterns showed that ropinirole hydrochloride was dispersed at the molecular level in the polymer matrix.  
Conclusion: The controlled release microparticles were successfully prepared and from this study, it was concluded that the developed 
microspheres of ropinirole hydrochloride can be used for controlled drug release to improve the bioavailability and patient compliance and to 
maintain a constant drug level in the blood target tissue by releasing the drug in zero order pattern. 
Keywords: Ropinirole hydrochloride microspheres, Eudragit RS 100, Eudragit RL 100, Ethylcellulose, Controlled release, Solvent evaporation 
technique 




The oral route is the most sought-after for the administration of 
drug molecules to the systemic circulation due to their ease of 
administration, better treatment, patient compliance and cost-
effectiveness [1]. But the limitation of the conventional dosage form 
has been recognized for some time now which includes frequent 
medication, plasma drug level fluctuation, inability to maintain the 
drug content at the site of action and variation in absorption or 
metabolism resulting in toxic effects. However, these problems can 
be resolved by designing a new drug delivery system [2]. Recently, 
extensive efforts have been dedicated to developing controlled 
release drug delivery system which is designed to release the drug 
constantly over an extended period of time. 
Controlled drug delivery by encapsulating the drug inside the 
polymeric carriers has achieved great progress in the last two 
decades due to the following reasons. A steady-state plasma 
concentration can be achieved by this system. It also enhances the 
drug release and decreases side-effects by drug localization at the 
site of action and by controlling the drug release [3]. 
Microspheres developed using bio-degradable polymers are widely 
used to achieve controlled release of drugs. The main advantage of 
bio-degradable polymer is that they can be broken down in a 
biologically friendly manner after their use [4].  
Several microencapsulation techniques have been developed but the 
appropriateness of the technique depends on the nature of drug and 
polymer. Among various methods developed for formulation of 
microspheres, the solvent evaporation method has gained much 
attention due to its ease of fabrication without compromising the 
activity of the drug [5]. 
Ropinirole hydrochloride is a non-ergoline dopamine D2 receptor 
agonist used in the treatment of Parkinson's disease. It has the 
ability to stimulate the dopamine receptor in the striatum of the 
brain. Ropinirole hydrochloride would be a right candidate for 
controlled release drug delivery due to its low molecular weight 
(260.37 D) and optimum log P value (2.3). Moreover, its low and 
non-linear oral bioavailability due to first pass metabolism along 
with disadvantage of its conventional therapy reported as "off 
phenomenon" demands better alternative for its delivery [6, 7]. 
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The rationale behind this study was to prepare the microspheres of 
ropinirole hydrochloride encapsulated in the eudragit and 
ethylcellulose polymer to control the release of the drug. Eudragit RS 
100 and eudragit RL 100 are water-insoluble pH independent 
polymers whereas ethylcellulose is a pH-dependent polymer. In 
addition, the drug release kinetics for the formulations developed 
was also evaluated. 
MATERIALS AND METHODS 
Materials 
Ropinirole hydrochloride was generously gifted by Central Drug 
Laboratory, Kolkata, India. Various polymers like eudragit RS 100 and 
eudragit RL 100 were purchased from Yarrow chem product, Mumbai, 
India; while Loba Chemie, Mumbai, India provided ethyl cellulose and 
magnesium stearate. Span 80 was purchased from Merck specialities 
Private Limited. The pure dug was of standard quality complying with 
official monographs. All the chemicals used for the analysis were of 
analytical grade complying with the official monograph. Deionised 
water (distilled) was used throughout the experimental procedure. 
Methods 
Drug-polymer compatibility study through physical compatibility 
study, FTIR, and DSC 
Before the preparation of microspheres, compatibility of the drug 
with polymers present in microspheres was performed. The physical 
compatibility study was conducted by sealing the physical mixtures 
(1:1) into 15 ml USP type III flint glass vials and stored in a stability 
chamber for 30 d at 40 °C and 75% relative humidity conditions to 
note the initial state (table 2) [7]. The Fourier transform infrared 
radiation (FTIR) spectral measurements were taken at ambient 
temperature using IR spectrophotometer (IR Prestige–21, Shimadzu 
make Japan). In this method peak of the pure drug was matched with 
that of polymer in the range of 4000-400 cm-1
Preparation of ropinirole hydrochloride microspheres 
 for 100 scans (fig. 1, 
fig. 2 and fig. 3) [8]. The differential scanning calorimetry (DSC) 
thermograms were obtained using DSC (Perkin Elmer (Singapore); 
MODEL–Pyris diamond) to investigate the presence of additional 
peaks or absence of peaks indicating possible polymer interactions 
or phase transformations (fig. 4, fig. 5 and fig. 6) [9]. 
Ropinirole hydrochloride microspheres were prepared by solvent 
evaporation technique [10-12]. Different amount of eudragit RS 100, 
eudragit RS100 and eudragit RL100 combinations and eudragit RS 
100 and ethyl cellulose combinations were dissolved in 15 ml 
acetone separately by using a magnetic stirrer (Remi Equipments, 
Model 2MIH Mumbai, India). The core material, ropinirole 
hydrochloride, was added to the polymer solution and mixed for 15 
min followed by addition of magnesium stearate (50 mg) and then 
mixed thoroughly. The resulting dispersion was added in a thin 
stream to a mixture of 100 ml light liquid paraffin and span 80 with 
constant stirring at 500 round per minute (rpm) using a mechanical 
stirrer (Remi Motors, Model No. RO123R, Mumbai, India). The 
stirring was continued for 3 h until the acetone is evaporated 
completely. The microspheres formed were filtered by using 
whatmann filter paper. The residue was washed 4-5 times with 50 ml 
portions of n-hexane. The product was then dried at room 
temperature for 24 h. The formulation containing drug: polymer ratio 
were coded as F1, F2, F3, F4, F5, F6, F7, F8, F9, F10, F11, and F12. The 
composition of various formulations was mentioned in table 1. 
 







Drug: eudragit RS 100 and 
eudragit RL 100 




F1 2 1:3 - - 50 
F2 2 1:4 - - 50 
F3 2 1:5 - - 50 
F4 2 1:6 - - 50 
F5 2 - 1:2.5:0.5 - 50 
F6 2 - 1:3:1 - 50 
F7 2 - 1:3.5:1.5 - 50 
F8 2 - 1:4:2 - 50 
F9 2 - - 1:2.5:0.5 50 
F10 2 - - 1:3:1 50 
F11 2 - - 1:3.5:1.5 50 
F12 2 - - 1:4:2 50 
F = formulation code of microspheres 
 
Evaluation of prepared controlled release microspheres 
Determination of particle size of microspheres 
The particle size of prepared microspheres from each batch was 
determined by the optical microscopy method using an ocular 
micrometer which was previously calibrated with a stage 
micrometer (table 3) [13]. 
Determination of percentage drug entrapment efficiency  
Drug-loaded microspheres (50 mg) were powdered and 
suspended in 50 ml distilled water and diluted with methanol. It 
was stirred for 15 min and filtered. Ropinirole content in the 
filtrate was determined by UV spectrophotometer (shimadzu 
1700, Japan) at 250 nm against phosphate buffer (pH 7.4) (table 3) 







Determination of percentage drug loading 
Drug-loaded microspheres (50 mg) were powdered and 
suspended in 100 ml methanol solutions and kept for 24 h. It was 
stirred for 5 min and filtered. Ropinirole content in the filtrate was 
determined UV spectrophotometer (shimadzu 1700, Japan) at 250 
nm (table 3) [15].  






Determination of percentage yield 
Thoroughly dried microspheres were collected and weighed 
accurately. The percentage yield was then calculated using formula 
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The angle of repose, bulk density, tapped density; Carr’s index and 
Hausner’s ratio were determined to assess the flow-ability of the 
prepared microspheres. 
Angle of repose 
It was measured by fixed funnel standing method. The accurately 
weighed granules were taken in a funnel. The height of the funnel 
was adjusted in such a way that the tip of the funnel just touches the 
apex of the heap of the granules. The granules were allowed to flow 
through the funnel freely on to the surface. The diameter of the 
powder cone was measured (table 4) [16]. It was calculated by using 




h = height of pile, θ = angle of repose, r = radius of base pile and<25-
excellent flow, 25–30-good flow, 30–40-passable,>40-very poor flow. 
Bulk density 
Apparent bulk density (ρb) was measured by pouring the pre-weight 
(M) blend into a graduated cylinder. The bulk volume (Vb
bρ
) of the 
blend was determined (table 4) [16-18]. Then the bulk density was 





The measuring cylinder containing a known mass (M) of the blend 
was tapped for a fixed time, and the minimum volume (Vt) occupied 
in the cylinder was measured (table 4) [17, 18]. The tapped density 
(ρ t
tρ





Carr’s index of the powder was determined for the determination of 
flow of the powder (table 4). It is calculated by using tapped density 
and bulk density [17, 18]. 





In Carr’s index, the value below 15% indicates a powder with usually 
give rise to good flow characteristics, whereas above 25% indicates 
poor flow-ability.  
Hausner’s ratio 
It gives information about flow-ability of the powder. It is 
determined by comparing the tapped density to the bulk density 
(table 4) [17, 18]. It is calculated by the following formula:  





Lower Hausner’s ratio (<1.25) indicates better flow properties than 
higher ones (>1.25). 
In vitro drug release study at pH 7.4 
In vitro release studies were performed by using USP-II type dissolution 
apparatus (paddle type). An accurately weighed sample (75 mg) of 
microspheres was suspended into 900 ml of phosphate buffer (pH 7.4) 
maintained at a temperature of 37 °C±0.5 °C and stirred at a speed of 100 
rpm (round per minute). At predetermined time intervals, a 5 ml aliquot 
of the sample was withdrawn and the volume was replaced with an 
equivalent amount of plain dissolution medium kept at 37 °C. The 
absorption of the filtered withdrawn sample was measured by UV 
spectrophotometer (Shimadzu 1700, Japan) with suitable dilution and 
the corresponding concentration was determined from the respective 
calibration curve. The temperature was maintained at 37 °C throughout 
the studies (fig. 7 and fig. 8) [19, 20]. 
In vitro drug release kinetics  
Kinetic models are best-known tools to describe the drug release 
pattern from immediate and modified release dosage forms. In order 
to investigate the kinetics and mechanism of drug release from 
prepared microspheres of different drug and polymers ratios, the 
release data were examined using zero order kinetic, first-order 
kinetic, higuchi kinetic and korsmeyer-peppas model (table 5) [21, 22]. 
Scanning electron microscope (SEM)  
Scanning electron microscopy was carried out to study the 
morphological characteristics of ropinirole hydrochloride 
microspheres of F12 formulation batch. It was carried out by 
sprinkling the microspheres on one side of an adhesive stub. The dried 
microspheres were coated with gold (100 Å) under an argon 
atmosphere in a gold coating unit and scanning electron micrographs 
(JEOL MAKE UK; MODEL-JSM 6360) were observed (fig. 9) [23].  
Fourier-transform Infra-red spectroscopy (FTIR)  
The IR spectrum was recorded using an FTIR spectrophotometer (IR 
Prestige–21, Shimadzu make Japan) by the KBr pellet method. The 
spectra obtained for ropinirole hydrochloride and formulation batch 
(F12) were compared (fig. 10). In this method peak of the pure drug 
was matched with that of the formulations in the range of 4000-400 
cm-1
Differential scanning calorimetry (DSC) 
 for 100 scans [23]. 
The DSC thermogram of pure drug and formulation batch (F12) was 
generated and investigated on a Perkin Elmer (Singapore); MODEL–
Pyris diamond TG/DTA. A sample weight of 10±2 mg was used in each 
experiment. The samples were heated from 30 °C to 400 °C at a heating 
rate of 10 °C/min in the nitrogen atmosphere (flow rate 150 ml/min) to 
investigate the presence of additional peaks or absence of peaks 
indicating the uniform dispersion of drug in the polymer (fig. 11) [24]. 
X-ray diffraction studies (XRD) 
X-ray diffraction measurements of the formulation batch (F12) and 
pure drug were recorded with a Model Ultima-III Rigaku make 
(Japan) diffractometer equipped with Ni-filtered Cu K α radiation (λ 
= 0.1548 nm) (fig. 12). The drug and microspheres were mounted on 
the sample holder and were scanned at a rate of 5 °/min in the angle 
2θ range of 5° to 60° [25].  
RESULTS AND DISCUSSION 
Preparation of microspheres 
Controlled release microspheres of ropinirole hydrochloride were 
prepared using polymers such as eudragit RS100, eudragit RL100, and 
ethyl cellulose either alone or in combination in various drug and 
polymer ratios as given in formulation composition of microspheres 
(table 1) with the help of non-aqueous solvent evaporation technique 
using acetone as the solvent system. After the introduction of drug and 
polymer solution in the acetone solution, an emulsion got formed. 
Agitation provided by stirrer broke the poured polymer solution into 
discrete droplets, forming an emulsion where polymer and drug were 
still in their solution form in the organic solvent. As the stirring 
continued, the acetone started to evaporate leading to co-precipitation of 
the drug and polymer at the interface of emulsion droplet. This co-
precipitation of drug and polymer resulted in a shell around droplet. In a 
previous study, it was reported that when the diffusion rate of solvent 
from emulsion droplet was too slow, microspheres coalesced together 
[26]. According to a previous report, diffusion of the organic solvents 
completed in the time span of 20 min leads to the hardening of 
microspheres [27]. 
Drug-polymer compatibility study  
Physical compatibility study  
Initially, the ropinirole hydrochloride and its physical mixture with 
polymers were white in color. Stability study between the drug and 
the polymer was conducted after the 15th and 30th day. No visible 
interaction between the drug and polymer was noticed. According to 
a previous study, change in temperature and humidity may lead to 
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the physical changes [28]. So, proper storage conditions were 
maintained for 30 d.  
FTIR 
The pure drug of ropinirole hydrochloride showed sharp 
characteristic peaks at 1703 and 1759 cm-1 for ketone group (C=O), 
3415 cm-1 for secondary amine group, 1596 cm-1 for tertiary amine 
group and 2881 and 2979 cm-1
DSC 
 for the alkyl group. All the above 
characteristics peaks of the drug also appear in the spectra of the 
drug with polymer-like eudragit RS100, eudragit RL100 and 
ethylcellulose. It shows that there was no alteration in the properties 
of the drug and polymers during the formulation. Hence the drug 
and polymers were compatible with each other.  
The DSC thermograph of ropinirole hydrochloride exhibits an 
endothermic peak at 248.36 °C corresponding to its melting point. 
The mixture of drug and polymers like eudragit RS 100 and 
eudragit RL 100 showed endothermic peaks at 244.08 °C and 
245.72 °C respectively which showed that the drug was 
compatible with both the polymers and there was no major 
interaction of drug and polymers. A slightly broadened peak was 
observed in the thermogram of the physical mixture ropinirole 
hydrochloride and ethylcellulose. In a previous study, it was 
reported that the presence of ethylcellulose in the physical 
mixture depressed the melting point of the drug slightly and 
broadened its melting point endotherm [29]. 
 
Table 2: Physical compatibility study 
Composition Description 
Initial 15 d 30 d 
Ropinirole hydrochloride white No colour change No colour change 
Ropinirole hydrochloride, eudragit RS 100 and eudragit RL 100 white No colour change No colour change 
Ropinirole hydrochloride and ethylcellulose white No colour change No colour change 
 
 
Fig. 1: FTIR spectra of pure ropinirole hydrochloride 
 
 
Fig. 2: FTIR spectra of a mixture of ropinirole hydrochloride, eudragit RL 100 and eudragit RS 100 
Kar et al. 




Fig. 3: FTIR spectra of a mixture of ropinirole hydrochloride and ethylcellulose 
 
 
Fig. 4: DSC thermogram of pure ropinirole hydrochloride 
 
 
Fig. 5: DSC thermogram of a mixture of ropinirole hydrochloride, eudragit RL 100 and eudragit RS 100 
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Fig. 6: DSC thermogram of a mixture of ropinirole hydrochloride and ethylcellulose 
 
Determination of particle size of microspheres 
All the microspheres obtained from non-aqueous solvent 
evaporation technique were discrete and spherical in shape. The 
optical microscopic study of particle size distribution revealed that 
the microspheres were uniform in size in each formulation with 
average diameter ranged from 90.01±3.00-130±4.16 µm. This may 
be due to the particle size is directly proportional to viscosity, where 
an increase in the viscosity upturns the droplet size. Hence, the 
adequate viscosity should be maintained. The particle size was 
maximum for the F12 batch with a maximum concentration of 
eudragit RS100 and ethylcellulose. According to a previous study, it 
was reported that the particle size increased with increase in ethyl 
cellulose concentration [30]. 
Determination of percentage drug entrapment efficiency  
The percentage drug entrapment efficiency ranged from 36.24% to 
95.07%. The effect of the combination of the polymers over 
encapsulation efficiency was convincing. The entrapment efficiency 
was found to be abruptly increasing when a combination of 
polymers was used and the maximum entrapment efficiency of 
95.07% was noted for the batch F12 with a high drug-polymer ratio 
of 4:2 containing a combination of eudragit RS100 and 
ethylcellulose. This ratio of polymers was found to be efficient of 
encapsulating maximum drug than any other batches. The addition 
of the polymer ethylcellulose along with eudragit RS100 increased 
the entrapment efficiency compared to the combination of eudragit 
RS100 and eudragit RL100. It was reported in the literature that the 
encapsulation efficiency depends on the solubility of the drug in the 
solvent and continuous phase. An increase in the concentration of 
polymer in a fixed volume of organic solvent resulted in an increase 
in encapsulation efficiency [31]. 
Determination of percentage drug loading 
The percentage drug loading ranged from 35.52% to 94.50%. Higher 
drug loading was observed in F12 containing a combination of 
eudragit RS 100 and ethylcellulose in the ratio 4:2. A higher 
percentage of loading was obtained by the addition of ethylcellulose 
polymer and by increasing the amount of polymer with respect to 
the drug. A study reported that various factors such as the drug to 
albumin ratio, the concentration of surfactant, stirring rate of the 
emulsion and average size of microspheres could affect drug loading. 
They found that drug loading could be increased by increasing the 
drug to albumin ratio, decreasing surfactant concentration and 
increasing the stirring rate [32]. 
Determination of percentage yield 
Percentage yield of all the formulations prepared from solvent 
evaporation technique was found in the range 55.67 to 80.09 % 
which is sufficiently high. As experimental result revealed 
percentage yield value was directly related to polymeric 
concentration rather than the combination of polymers used. 
According to a previous study, as the polymer concentration was 
increased, percentage yield was also increased [33]. 
 
Table 3: Particle size analysis, drug entrapment efficiency, percentage drug loading and percentage yield of microsphere formulation F1-F12 
Formulation 
code 
Average particle size 
(µm)
Percentage drug entrapment 
efficiency* 




F1 90.01±3.00 36.24±1.03 35.52±0.57 55.67±0.34 
F2 92.05±3.35 47.92±0.44 46.75±0.67 63.34±0.28 
F3 95.01±4.42 60.25±0.92 59.03±1.03 70.00±0.62 
F4 100.56±3.05 83.56±0.66 82.30±0.45 74.00±1.15 
F5 94.62±2.00 45.69±1.06 44.45±0.64 56.88±0.64 
F6 95.64±2.48 53.72±0.43 52.45±0.55 64.92±1.10 
F7 101.26±4.16 67.45±0.33 66.84±0.72 72.36±0.55 
F8 102.34±4.58 89.52±0.25 88.95±0.89 76.02±0.82 
F9 94.72±2.64 39.65±0.69 38.10±0.99 58.65±0.98 
F10 110.64±1.67 59.98±0.73 58.04±1.02 66.66±1.05 
F11 112.26±3.89 78.84±1.06 77.54±0.46 73.05±0.87 
F12 130.00±4.16 95.07±0.48 94.50±0.56 80.09±0.99 
*Each reading is an average of three determinations (mean±SD) (n=3) n = no of observation F= formulation code of microspheres 
 
Rheological properties 
Flow properties of batches were evaluated by measuring the angle of 
repose and Carr's index. Microspheres showed the desired flow-
ability due to the optimal presence of moisture, spherical shape, and 
diminished cohesiveness. The pure drug showed the angle of repose 
of 35.19 and exhibited poor flow, whereas the angle of repose of all 
the formulations showed excellent flow-ability and ranged from 
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30.10 to 32.30. The bulk density and the tapped density of all the 
formulations were within short range, i.e. 0.66 g/cm3 to 0.66 g/cm3 
and 0.73 g/cm3 to 0.76 g/cm3
 
 respectively. The Carr's index of all the 
formulations exhibited excellent flow properties and ranged from 
13.15 to 9.58 as compared to the pure drug, which was 24.39 
indicating poor flow-ability before formulating to microspheres. 
Hausner’s ratio of the pure drug was 2.16, which indicated poor 
flow-ability, but the formulated microspheres exhibited good flow 
properties that ranged from 1.15 to 1.10. According to a previous 
study, it was reported that in the evaluation of flow-ability of dry 
solid, the substance showed excellent flow-ability and performance, 
when the angle of repose has the value less than 25 °, while when 
compressibility index has a value below 9%, no aid was needed for 
enhancing the flowability of the powder. Thus, the angle of repose 
and compressibility index is indicative of good flow-ability of 
microspheres, showing no need for the addition of glidants to 
enhance flow-ability [34, 35]. The better flow property of 
microspheres indicated that the microspheres produced were non-
aggregated. The improved rheological properties of formulated 
microspheres, when compared to that of the pure drug alone, 
suggested that they could be easily handled and filled into a 
capsule. Excellent flow properties of prepared microsphere 
suggested less poly-dispersity, complete drying and particle size 
uniformity. 
Table 4: Rheological characteristics of microsphere formulations F1 to F12 
Formulation code Angle of repose ( °) Bulk density (g/cm* 3) Tapped density (g/cm* 3) Carr’s Index* Hausner’s ratio* * 
F1 30.10±2.27 0.66±0.003 0.76±0.007 13.15±0.36 1.15±0.072 
F2 32.24±1.16 0.66±0.003 0.76±0.007 13.15±0.36 1.15±0.072 
F3 31.33±3.13 0.65±0.001 0.77±0.007 15.58±0.14 1.18±0.010 
F4 33.42±1.14 0.67±0.013 0.75±0.015 10.66±0.52 1.11±0.004 
F5 32.37±1.15 0.65±0.001 0.73±0.014 10.95±0.66 1.12±0.002 
F6 30.12±3.32 0.67±0.013 0.76±0.007 11.84±1.03 1.13±0.001 
F7 35.66±3.02 0.68±0.007 0.79±0.002 13.92±0.44 1.16±0.008 
F8 34.69±2.49 0.66±0.003 0.75±0.005 12.00±0.59 1.13±0.001 
F9 32.40±2.33 0.67±0.013 0.77±0.007 12.98±0.72 1.14±0.004 
F10 33.51±1.78 0.64±0.005 0.78±0.020 17.94±0.74 1.21±0.020 
F11 34.15±2.87 0.66±0.003 0.76±0.007 13.15±0.42 1.15±0.012 
F12 32.30±1.98 0.66±0.003 0.73±0.014 9.58±1.05 1.10±0.005 
*Each reading is an average of three determinations (mean±SD) (n=3) n = no of observation, F= formulation code of microspheres 
 
In vitro drug release study at pH 7.4 
Different release profiles were observed with each combination of 
polymers. For formulation F1 to F4, eudragit RS100 was used alone 
and hence drug release was observed till the 13th hour of 
dissolution study. The formulation containing eudragit RS 100 
showed less drug release because it is the least permeable polymer 
due to the presence of less quaternary groups than that in eudragit 
RL 100. According to a previous study, it was reported from the 
release data of different formulations, that the cumulative 
percentage release of drug from the microspheres depends upon the 
type, amount and combination of polymer used [36]. For 
formulation F5 to F8, a combination of eudragit RS100 and eudragit 
RL100 was used releasing the drug until the 12th hour because a 
higher concentration of eudragit RS100 was used compared to 
eudragit RL100 which is more permeable. Formulations F9 to F12 
were prepared using a combination of ethylcellulose and eudragit 
RS100. F12 showed 7.35% of cumulative drug release at first hour. 
The rate of release of formulation F12 was very much controlled 
because of the combination of polymers of ethylcellulose and 
eudragit RS100. When both these polymers were combined, they 
form a polymeric matrix of high density leading to the formation of a 
strong polymeric network due to the presence of ethylcellulose. In a 
previous study, it was reported that the non-toxic, non-allergic and 
non-irritant behaviour of ethylcellulose make this polymer one of 
the best for the formulation of microspheres [36, 37]. From the 
present study, it was observed that the formulations prepared from 
this polymer possess lower densities and was expected to be 
retained in the site-specific delivery for a prolonged period of time. 
Most of the formulations prepared from ethyl cellulose and eudragit 
RS100 did not show any burst effect or lag time which indicates 
homogeneous drug distribution. The release of F9 to F11 was higher 
than that of F12 because at lower polymer concentration smaller 
microspheres were formed. According to a previous study, due to 
the small size of microspheres larger surface area was exposed to 
dissolution medium giving rise to faster drug release [37]. 
 
 
Fig. 7: Cumulative % drug release profiles of formulations F1-F6. Each reading is an average of six determinations (mean±SD) (n=6) n=no. 
of observation 
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Fig. 8: Cumulative % drug release profiles of formulations F7-F12. Each reading is an average of six determinations (mean±SD) (n=6) n = 
no. of observation 
 
In vitro drug release kinetics 
The results of the in vitro drug release study obtained from the 
different batches were plotted using kinetic models. Zero-order 
kinetics, first-order kinetics, Higuchi’s matrix and Korsmeyer-
Peppas model were used to evaluate the release mechanism from 
ropinirole hydrochloride microspheres. The kinetic model showing 
highest correlation coefficient (R2) was considered as the most 
appropriate model for the dissolution data. Korsmeyer model is 
widely used; when the release mechanism is not well known or 
when more than one type of release phenomena could be involved. 
Korsmeyer-Peppas equation: Mt/Mµ = Ktn, where Mt/Mµ
  
 is the 
fractional drug release in time‘t’, K= constant incorporating of 
structural and geometric characteristics of the controlled release 
device, n = diffusional release exponent indicative of release 
mechanism. The ‘n’ value could be used to characterize different 
release mechanisms as follows n = 0.5 means Fickian diffusion, 
0.5<n<1.0 non-Fickian diffusion, and n = 1.0 Case II diffusion. The 
interpretation of data was based on the value of the resulting 
regression coefficients. The best fit with the highest correlation 
coefficient was observed in the Korsmeyer-Pappas model and zero-
order release kinetics followed by Higuchi model. The ‘n’ value of the 
formulations indicated that the drug release followed anomalous 
(non-fickian) diffusion. In a previous, study it was reported, that the 
variation in polymer concentration greatly affects the release 
kinetics and the diffusion mechanism [38]. 
Table 5: In vitro dissolution kinetics data of formulations F1 to F12 
Formulations Zero-order model First order model Higuchi model Korsmeyer-pappas model 
R R2 R2 R2 n 2 
F1 0.999 0.941 0.982 0.999 0.926 
F2 0.999 0.853 0.978 0.998 0.876 
F3 0.990 0.903 0.992 0.994 0.858 
F4 0.999 0.797 0.969 0.992 0.897 
F5 0.999 0.930 0.979 0.999 0.988 
F6 0.992 0.854 0.963 0.996 0.969 
F7 0.997 0.861 0.966 0.997 0.942 
F8 0.999 0.823 0.978 0.998 0.915 
F9 0.999 0.933 0.977 0.997 0.906 
F10 0.996 0.900 0.985 0.996 0.920 
F11 0.998 0.831 0.972 0.998 0.890 
F12 0.999 0.795 0.976 0.999 0.977 




Characteristics of the optimized microsphere batch 
On the basis of all the evaluation parameters, formulation F12 was 
selected as the most optimized formulation, and its statistical 
evaluation was done using analysis of variance (ANOVA) at P<=0.05 
significance level and it was found to be statistically significant with 
P value<0.05. 
Scanning electron microscope (SEM)  
= Regression correlation coefficient, n= diffusion coefficient, F= formulation code of microspheres 
Scanning electron microscopy was done to determine the surface 
microscopy and internal texture of F12 microspheres. 
Photomicrograph of the microspheres before and after the release of 
drugs was taken. The quality of the microspheres (with respect to 
surface properties) and the nature and size of pores developed on 
the surface was studied. It revealed that the F12 microspheres 
possessed a rough and porous surface. The micrograph taken after 
14 h release studies also revealed porosity developed at the surface 
and no visible major surface irregularity and the structure remained 
retained as 14 h drug release study was carried out. According to a 
previous study, it was reported that the changes that occur during in 
vitro dissolution studies may have implications to the performance 
of the microspheres [39]. 
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Fig. 9: SEM images of the optimized F12 microspheres before and after dissolution study 
 
Fourier-transform infrared spectroscopy (FTIR)  
The pure drug showed sharp characteristic peaks at 1703 and 1759 
cm-1 for ketone group (C=O), 3415 cm-1 for secondary amine group, 
1596 cm-1 for tertiary amine group, 2881 and 2959 cm-1for the alkyl 
group, 1071.77 cm-1 for-C-O-stretching and 781.93 cm-1
 
 for-C-H-
rocking vibration. All these characteristics peaks also appeared in 
the F12 microspheres without any change. This indicated that 
ropinirole hydrochloride did not undergo any chemical changes 
while forming the microspheres. 
 
Fig. 11: FTIR spectra of pure drug and formulation F12 microsphere 
 
Differential scanning calorimetry (DSC) 
The DSC thermogram of pure drug exhibited a single sharp 
endothermic peak at 248.36 °C corresponding to its melting 
transition temperature. In case of F12 microspheres, no 
characteristic peak was observed at 248.36 °C which indicated that 




Fig. 10: DSC thermograms of pure drug and formulation F12 microsphere 
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X-ray diffraction studies (XRD) 
The drug peaks of pure drug were observed at 2θ of 5.5 °, 18.2 °, 
22.4 °, 24.8 ° and 25.3 ° which was due to crystalline nature of 
ropinirole hydrochloride, while in the case of drug-loaded 
microspheres of F12, these peaks of the drug were not observed 
which indicated that the drug particles were dispersed at molecular 
level in the polymer matrix. 
 
 
Fig. 12: XRD spectra of pure drug and formulation F12 microspheres 
 
CONCLUSION 
The present studies, therefore, shows the successful formulation of 
controlled release microspheres of ropinirole hydrochloride by the 
solvent evaporation method using eudragit RS100, eudragit RL100, 
and ethylcellulose as suitable polymers. This study has been a 
satisfactory attempt to formulate a micro-particulate system of 
ropinirole hydrochloride with a view of controlled delivery of the 
drug. In the formulation, the combination of cost-effective and bio-
compatible polymers of eudragit RS100 and ethylcellulose had been 
successfully used and there is a scope of scale-up of the batches to 
the commercial level. Physical compatibility study, FTIR and DSC 
studies used for drug-polymer compatibility study confirmed the 
absence of any physiochemical interaction between the drug and 
polymers. The formulation was found to be efficient with good 
percentage entrapment efficiency, percentage drug loading and 
percentage yield. The surface structure, particle size and flow 
analysis revealed that the microspheres showed good flow and pack-
ability, indicating that it can be successfully handled and filled into a 
capsule dosage form. In vitro drug release showed a prolonged and 
controlled release of ropinirole hydrochloride employing phosphate 
buffer as release media. The drug release was found to be polymer 
concentration dependent. It was best explained by zero-order 
kinetics and followed non-fickian diffusion mechanism. SEM analysis 
showed a rough and porous surface with the spherical appearance of 
microspheres. FTIR studies showed that ropinirole hydrochloride 
did not undergo any chemical changes while forming the 
microspheres. DSC thermograms and XRD spectra revealed that the 
drug particles were dispersed uniformly at the molecular level in the 
polymer matrix. Hence, the controlled release microsphere 
formation of ropinirole may provide a convenient dosage form for 
achieving best performance regarding flow, drug entrapment, and 
release. Further, their potential to improve the bioavailability of 
ropinirole in human needs to be investigated in further studies. 
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